Introduction
Individuals carrying germline mutations in the von Hippel ± Lindau (VHL) tumor suppressor gene are predisposed to VHL disease, a hereditary cancer syndrome which manifests as renal cell carcinoma (RCC), pheochromocytoma and hemangioblastomas of the central nervous system (Latif et al., 1993; Linehan et al., 1995) . Inactivation of the VHL gene has been demonstrated in both VHL disease and a majority of sporadic RCCs , and loss of VHL function appears to be an early event in RCC (Lubensky et al., 1996) . Furthermore, reintroduction of wild-type VHL expression into VHL-negative renal cells abrogates their tumorigenicity (Iliopoulos et al., 1995; Schoenfeld et al., 1998) . Thus, the VHL tumor suppressor gene blocks the development and progression of renal cell carcinogenesis.
There exists two endogenous products of the VHL gene: the full length VHLp24(MPR), and the more abundant VHLp18(MEA), created by internal translation initiation . Both VHLp24(MPR) and VHLp18(MEA) can form complexes with elongins B and C and cul-2 (Blankenship et al., 1999; Iliopoulos et al., 1998; Schoenfeld et al., 1998) . Additionally, both of these VHL proteins have equivalent biological activities, including tumor suppression in nude mice .
VHL gene products appear to be involved in the regulation of various cellular stress responses. For example, VHL down-regulates the expression of hypoxia-inducible genes such as vascular endothelial growth factor (VEGF), glucose transporter, GLUT1 and platelet derived growth factor (PDGF) B chain (Iliopoulos et al., 1996) , likely via degradation of hypoxia-inducible factor (HIF) a subunits (Maxwell et al., 1999; Ohh et al., 2000) . In addition, VHL expression (in VHL-null RCC cells) provides protection from the cytotoxic eects of serum withdrawal and glucose deprivation (Gorospe et al., 1999; Pause et al., 1998) . Here, we examine the role of VHL in response to cytotoxic ultraviolet (UV) irradiation. We report that VHL-de®cient renal carcinoma cells are sensitive to the eects of UV exposure and moreover, that VHL expression protects these cells from UV-mediated apoptosis. The implications of these ®ndings with regards to tumor development are discussed.
Results

VHL protects against dose-dependent UV-mediated apoptosis
To examine whether exposure to UV has dierential eects on VHL-negative and VHL-positive 786-O renal carcinoma cells, the parental 786-O cell line was compared to cells stably expressing either the VHLp24(MPR) or VHLp18(MEA) products of the VHL gene . Con¯uent culture dishes of cells (see Materials and methods) were subjected to incremental doses of UV irradiation. Apoptosis was initially detected by anti-poly (ADPribose) polymerase (PARP) Western blotting of cell lysates collected 24 h after UV irradiation. An 85 kDa cleaved PARP fragment, indicative of apoptosis, was detected in cell lysates from parental 786-O cells, but not from cells expressing either VHLp24(MPR) or VHLp18(MEA) (Figure 1a ). As the UV dosage was incrementally raised from 15 J/m 2 to 45 J/m 2 , levels of the cleaved PARP fragment in 786-O cell lysates also increased, indicating a dose-dependent apoptotic response to UV.
To examine the time course of apoptosis in these cell lines, a panel of VHL-negative and VHL-positive 786-O cells were utilized (Figure 1b) . VHL-negative cell lines included; parental 786-O cells, 786-O cells stably transfected with the empty pCR3 vector and 786-O cells stably expressing either VHL deletion mutants, VHL(MPR)del(114 ± 178) and VHL(MEA)del(114 ± 178), or the VHL point mutant, VHLp24(MPR)R 167W (Arg-167 to Trp). The R 167 W mutation renders VHL products defective in elongin B and C binding (Duan et al., 1995) . The deletion mutations have been previously shown to be de®cient in VHL biological activities . In all of the VHL-negative cell lines tested, the 85 kDa PARP cleavage product was detected in lysates collected 8 and 24 h after exposure to 45 J/m 2 UV (Figure 1b) . In cells expressing the R 167 W mutant, PARP cleavage was detected earlier, at 2 h post-UV exposure. The PARP cleavage product was not present in lysates from VHLpositive cells at any time following UV treatment.
In order to provide additional support that PARP cleavage seen with VHL-negative 786-O cells was truly indicative of apoptosis, we performed TUNEL analysis (Figure 2 ). Cells grown on coverslips were subjected to 45 J/m 2 of UV and assayed 24 h later. In accord with the PARP analysis, VHL-negative cell lines displayed TUNEL staining following UV treatment, whereas VHL-positive cell lines were virtually devoid of TUNEL labeling. No substantial TUNEL staining was seen in cells not subjected to UV (data not shown). FACS analysis corroborated the TUNEL data: an increase in sub-G 1 DNA content was observed in VHL-negative, but not VHL-positive cell lines following UV treatment (data not shown). Thus, VHL-negative 786-O cells undergo UV-mediated apoptosis, whereas VHL-positive cells do not.
UV-mediated apoptosis of VHL-negative 786-O cells occurs without p53 activation
In order to account for the observed dierences in UVmediated apoptosis between VHL-negative and VHLpositive cells, we examined cellular eectors and regulators of the apoptotic response. Activation of the p53 tumor suppressor gene can lead to apoptosis or growth arrest in speci®c cell types (reviewed in Agarwal et al., 1998; Levine, 1997; Lowe and Lin, 2000) . The p53 protein is phosphorylated at N-terminal Ser residues following UV irradiation, resulting in stabilization of p53 protein (i.e., increased protein levels) (Shieh et al., 1997 (Shieh et al., , 1999 Siliciano et al., 1997) . 786-O cells contain wild-type p53 (RD Burk, unpublished observations). However, p53 levels did not increase in response to UV treatment in any of the 786-O cell lines (Figure 3a) . In fact, p53 was abundant in untreated cells, being readily detected (using mAb DO-1) in as little as 10 mg of protein lysate (Figure 3a ). This implies that p53 is constitutively stabilized in 786-O cells, perhaps indicating that either p53 exists in a latent form in these cells or that the p53 pathway is altered and/or compromised in some manner. However, it is unlikely that p53 is inactivated through cytoplasmic sequestration because p53 was detected in the nucleus in 786-O cells (data not shown).
Activated p53 is capable of transactivating a number of target genes, including the pro-apoptotic product, Bax, and the growth-suppressing cyclin-dependent kinase inhibitor, p21 (Levine, 1997) . To assess whether UV-mediated apoptosis was occurring through upregulation of Bax, we performed anti-Bax Western p21 and p27 undergo UV-mediated proteasomal degradation in VHL-negative, but not VHL-positive
786-O cells
We next examined the mechanisms whereby wild-type VHL expression protects UV-treated cells from apoptosis. Since apoptosis can result from perturbation of cell cycle checkpoints, growth regulatory proteins were analysed. p21 and p27 belong to the Cip/Kip family of cyclin-dependent kinase (CDK) inhibitors that mediate cell cycle arrest. We assayed (by Western blotting) for UV-mediated changes in the levels of these CDK inhibitors in the 786-O cell lines (Figure 4) . Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) using¯uorescein-dUTP was performed 24 h after UV treatment (left panels). Cells were also incubated in 4',6' Diamidino-2-phenylindole (DAPI, 0.25 mg/ml in PBS) for 5 min to visualize nuclei (right panels). Cells expressing the R 167 W mutant VHLp24(MPR) product failed to reach an equivalently high cell density as the other 786-O cell lines Figure 3 Western blot analysis of p53, Bax, and phospho JNK. 786-O cell lines (indicated to the left of each blot) were exposed to 45 J/m 2 of UV. Whole cell lysates were collected at time intervals indicated above blots. 786-O whole cell lysates were identical to those used in Figure 1b . Whole cell lysates were normalized for equal protein loading (10 mg) in each lane of either a split 8%/ 13% polyacrylamide SDS ± PAGE gel (in a and b) or a 10% SDS ± PAGE gel (in c). Western blotting was performed using antibodies to (a) p53, (b) Bax and (c) phosphorylated c-Jun Nterminal kinase (phospho JNK). In (c), positions of the 54 and 46 kDa isoforms of JNK are indicated to the right. Equivalent levels of non-phosphorylated JNK were observed on a separate Western blot (data not shown) Strikingly, levels of both p21 and p27 dropped precipitously following UV treatment in VHL-negative lines (Figure 4a,b, left panels) . In contrast, p21 and p27 levels remained constant in VHL-positive cells.
Since p21 and p27 have been previously shown to undergo proteasome-dependent degradation (Blagosklonny et al., 1996; Pagano et al., 1995) , we investigated whether the observed decreases in p21 and p27 in VHL-negative cell lines following UV treatment occurred in this manner. The 786-O cell lines were incubated with the irreversible proteasomal inhibitor lactacystin for 1 h prior to UV treatment and assayed as previously. Indeed, proteasomal inhibition blocked the UV-mediated decreases in p21 and p27 ( Figure  4a ,b, right panels). Lactacystin treatment did not increase the abundance of these CDK inhibitors in VHL-positive cells, however. Therefore, UV treatment leads to proteasomal degradation of p21 and p27 in VHL-negative, but not VHL-positive cell lines.
During our analyses of the CDK inhibitors, we also noted that the levels of p21 and p27 were higher in VHL-positive cells than VHL-negative cells prior to UV treatment (Figure 4a,b, 0 h ). Since these experiments were performed using multiple Western blot membranes, we assessed the steady state levels of these CDK inhibitors in the 786-O cell lines on the same Western blot (Figure 4c) . As in the previous experiments, densely grown 786-O cell lines were utilized. Levels of p21 and p27 were higher in VHL-positive cell lines than VHL-negative lines (Figure 4c ). However, VHL-positive cell lines were not growth arrested prior to UV treatment and did not exhibit a signi®cantly dierent rate of growth than VHL-negative cells (see Figure 5 ). This may indicate that VHL-positive cells are poised for growth arrest in response to an additional stimulus, such as UV irradiation. The UVdependent degradation of p21 and p27 in VHLnegative cells further widens the disparity in levels of these CDK inhibitors between VHL-positive and VHLnegative cell lines. These dierences may explain, at least in part, the protection of VHL-positive cells from UV-mediated apoptosis.
VHL-positive cells have a decreased S-phase following UV treatment, while VHL-negative cells have an increased S phase
To determine whether VHL-positive cells undergo growth arrest in response to UV irradiation, we performed FACS analysis ( Figure 5 ). Again, highly con¯uent 786-O cell lines were assayed. Before UV treatment, both VHL-negative and VHL-positive cells were actively growing, with at least 10% of cells in S phase ( Figure 5, left panel) . VHL-expressing cells had a slightly higher (by 3 ± 5%) proportion of S phase cells. However, upon UV treatment, VHL-negative cells showed an almost twofold increase in S phase ( Figure  5 , right panel). In contrast, VHL-positive cells Figure 4 Western blot analysis of CDK inhibitors, p21 and p27. (a and b, left panels) 786-O cell lines (indicated to the left of each blot) were exposed to 45 J/m 2 of UV. Whole cell lysates were collected at time intervals indicated above blots. 786-O whole cell lysates were identical to those used in Figure 1b . Whole cell lysates were normalized for equal protein loading (10 mg) in each lane of a 13% SDS ± PAGE gel. Western blotting was performed using antibodies to (a) p21 and (b) p27. (a and b, right panels) Experiment was performed as above except cells were incubated with lactacystin (10 mM) for 1 h prior to UV treatment. (c) Lysates from the 0 h time point (untreated) in a and b were lysates were normalized for equal protein loading (10 mg) in each lane of a 13% SDS ± PAGE gel. Western blotting was performed using antibodies to p21, p27 and a-tubulin (as a control for equal protein loading), as indicated to the left of each panel Figure 5, right panel) . A moderate cell cycle block at G 1 phase (7 ± 11% increase in G 1 ) was observed for VHL-positive, but not VHL-negative cells following UV treatment (data not shown).
The increased S phase in VHL-negative cells following UV exposure suggests an inappropriate cellular response to DNA damage and may re¯ect an inability of these cells to adequately repair DNA damage. It is not known whether the enhanced S phase in VHLnegative cells resulted from increased cell division or from longer lengths of time needed to complete DNA synthesis. Regardless, UV-mediated apoptosis of VHLnegative cells likely occurred as cells continued to proliferate while containing damaged DNA. Conversely, VHL-positive cells did not experience increased cell cycling following UV, but instead had a greater G 1 population, suggesting that damaged DNA is adequately repaired. VHL-positive cells may be at least partially protected from apoptosis in this manner.
VHL-positive cells have elevated levels of Bcl-2 and Bcl-xL
Since UV treatment only led to a moderate G 1 phase accumulation in VHL-positive cells and did not cause full cell cycle arrest, we sought to determine additional mechanisms of VHL-mediated protection from UV. VHL-positive and negative cells were assayed by Western blotting for the anti-apoptotic proteins, Bcl-2 and Bcl-xL. Both Bcl-2 and Bcl-xL were more abundant in VHL-positive cells (Figure 6 ). In all of the cell lines utilized, Bcl-2 levels remained constant following UV treatment (data not shown). Thus, VHLmediated protection from apoptosis may also be a result, at least in part, of increased Bcl-2 and Bcl-xL levels.
Discussion
The data presented in this study demonstrates that VHL-negative cell lines undergo apoptosis in response to UV exposure. Cell death has been previously reported to occur to VHL-negative cells as a result of serum withdrawal (under certain growth conditions) and glucose deprivation (Gorospe et al., 1999; Pause et al., 1998) . This implies that loss of wild-type VHL renders renal cells sensitive to various cellular stresses and apoptotic stimuli. Increased apoptosis in cells containing mutant VHL (i.e., VHL-negative cells) may provide selective pressure for cells which can escape death under these or other conditions (Lowe and Lin, 2000) . The clonal outgrowth of VHL-negative cells that have evaded apoptosis may then lead to tumorigenesis.
It has been reported that VHL expression allows 786-O cells to exit the cell cycle and enter G 0 quiescence (Pause et al., 1998) . However, protection from UV-mediated apoptosis did not occur in this manner. In fact, we detected no cell cycle arrest of VHL-positive cells prior to UV treatment, in spite of the high cell densities utilized (see Materials and methods). These VHL-positive cells are not defective in VHL-mediated tumor suppression, however, since these cells have demonstrated growth suppression in a nude mice assay . Although quiescence was not achieved, VHL expression did prevent UV-dependent increases in cell cycling and led to a greater percentage of cells in G 1 phase.
The opposite eect, increased cell cycling due to UV, was seen with VHL-negative cells. Thus, UV treatment may have acted as a mitogenic stimulus in these assays, leading to a hyperproliferative state in VHL-negative cells. Oncogenes which drive cellular proliferation often promote apoptosis (Lowe and Lin, 2000) . Apoptosis may also occur due to the absence of appropriate cell cycle controls, such as those provided by the retinoblastoma (Rb) gene product. Accordingly, VHL-negative cells are marked by degradation of cdk inhibitors, p21 and p27 following UV treatment, whereas VHL-positive cells have higher levels of these inhibitors and are able to stabilize these proteins. As a result, VHL-positive cells experience diminished cell cycling in response to UV. Additionally, the antiapoptotic Bcl-2 and Bcl-xL are more abundant in VHL-positive cells. Thus, through diminished cell cycling and increased levels of Bcl-2 and Bcl-xL, VHL-positive cells are protected from UV-mediated apoptosis.
It is unclear how expression of wild-type VHL mediates the stabilization of p27 and p21. It may seem counterintuitive that VHL, which has been shown to be associated with ubiquitin ligase activities (Iwai et al., 1999; Lisztwan et al., 1999) , can also act to block the proteasomal degradation of p21 and p27. However, it is possible that VHL gene products sequester cellular factors such as Rbxl and Nedd8 which facilitate p27 (and perhaps p21) degradation (Morimoto et al., 2000) . Alternatively, the stabilization of these cdk inhibitors may occur through less direct mechanisms. One possibility is that VHL may increase the half lives of p21 and p27 mRNAs, perhaps through the degradation of factors that destabilize speci®c mRNA, in a manner opposite to HIF a subunits. Interestingly, although proteasomal inhibition stabilized p21 and p27 levels, we were unable to detect slower-migrating, ubiquitinated forms of p21 and p27. Thus, p21 and p27 stabilization may occur at the post-transcriptional level. Accordingly, UV treatment has been shown to induce a reduction in p21 mRNA levels (Lu et al., 1996) . VHL expression might somehow in¯uence this phenomenon. Additionally, VHL-dependent increases in p21 and p27 levels might be related to the observation that VHL-positive 786-O cells are more dierentiated than their VHL-negative counterparts Figure 6 Western blot analysis of Bcl-2 and Bcl-xL. Western blotting on lysates from untreated cells (as in Figure 4c ) was performed using antibodies to Bcl-2, Bcl-xL and a-tubulin (as a control for equal protein loading), as indicated to the left of each panel (Lieubeau-Teillet et al., 1998 and EJ Davidowitz, unpublished observations) . The dierentiation of VHL-positive cells might allow for decreased cell cycling (via p21 and p27) following UV treatment. Additionally, increased levels of Bcl-2 and Bcl-xL in VHL-positive cells might also occur as a result of VHL-mediated dierentiation.
While loss of VHL function may be an initiating event in tumorigenesis, it is likely that additional genetic events must occur prior to tumor formation. It is interesting that VHL-negative 786-O renal carcinoma cells (which have been an invaluable resource in demonstrating VHL function) are also de®cient in another tumor suppressor gene, namely PTEN (Ramaswamy et al., 1999) . Loss of PTEN leads to constitutive activation of the phosphatidylinositol 3-kinase pathway, including the downstream target, Akt (Di Cristofano and Pandol®, 2000) . Akt is a survival factor with anti-apoptotic activities. 786-O cells contain high levels of phosphorylated (activated) Akt (Ramaswamy et al., 1999) , which may have allowed them to escape apoptosis in vivo and under normal growth conditions. However, in response to UV irradiation, VHL-negative 786-O cells underwent apoptosis in spite of constitutive Akt activation. As a possible explanation for this apparent contradiction, transient Akt dephosphorylation was observed following UV treatment (data not shown), providing a window of time during which 786-O cells are not protected by Akt. However, deactivation of Akt was equivalent for both VHL-negative and VHL-positive cells. Additionally, there were no dierences between VHL-negative and VHL-positive cells in levels of activated Akt before UV treatment. Thus, the VHL-dependent protection of 786-O cells from UV-mediated apoptosis probably does not occur through the PTEN/Akt pathway.
The collective data indicates that VHL-negative 786-O cells continue to proliferate in spite of cellular stresses: UV (in this study), removal of serum (Pause et al., 1998) , and glucose deprivation (Gorospe et al., 1999) . This inappropriate proliferation probably results in the accumulation of mutations, some of which may allow cells to elude the apoptotic response, resulting in tumorigenesis. In contrast, VHL expression protects against aberrant growth in the presence of these cellular stresses. This protective eect of VHL is likely to be an important mechanism underlying VHLmediated tumor suppression.
Materials and methods
Plasmids and cell culture
VHL expression plasmids were constructed as previously described . Internal deletion (amino acids 114 ± 178) and point mutations of the VHL coding region were also created as previously described . 786-O renal carcinoma cells were obtained from the ATCC (Rockville, MD, USA). For all experiments, cells were grown in Dulbecco's modi®ed Eagle medium (DMEM) containing 10% fetal calf serum (FCS). Stable transfection of 786-O renal carcinoma cells was performed as described . Protein expression of VHL constructs was con®rmed by Western blotting (and data not shown).
UV treatment
Cells were grown at 100% con¯uence for 1 week, trypsinized, replated at 100% con¯uence in either 35 or 60 mm culture dishes, and cultured for three additional days prior to treatment. UV treatment was performed using a 254 nm (UVC) germicidal lamp at a dose rate of 1.5 J/m 2 /s. Medium was removed and cells were exposed to UV (0, 15, 30 or 45 J/ m 2 ) or, for time course experiments, 45 J/m 2 of UV. After UV treatment, cells were cultured in medium for either 24 h prior to analysis or for shorter periods of time (i.e., for time course experiments), as indicated. For zero time points, cells were not treated with UV. In some experiments (as indicated), lactacystin (10 mM; Calbiochem, La Jolla, CA, USA) was added to the culture medium for 1 h prior to UV treatment.
Analysis of apoptosis
For terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) analysis, cells were plated on glass cover slips in 35 mm culture dishes prior to UV treatment. TUNEL was performed with the In Situ Cell Death Detection Kit. Fluorescein (Boehringer Mannheim, Mannheim, Germany), according to the manufacturer's recommendations. Cells were then incubated in 4',6'-Diamidino-2-phenylindole (DAPI, 0.20 mg/ml in PBS) (Sigma, St Louis, MO, USA) for 5 min to stain nuclei. Coverslips were inverted and mounted on slides with Gel/Mount (Biomeda, Foster City, CA, USA). For¯ow cytometry analysis, cells were collected, washed in PBS and ®xed in 70% ethanol at 48C. Cells were incubated in PBS containing 0.1% Triton X-100. RNase A (0.2 mg/ml; Sigma) and propidium iodide (20 mg/ml). DNA content was analysed by a¯uorescence-activated cell sorter (FACScan, Becton Dickinson, Franklin Lakes, NJ, USA)
